Rox, a Rifamycin Resistance Enzyme with an Unprecedented Mechanism of Action

Abdelwahab, 2016, Mechanism of rifampicin inactivation in Nocardia farcinica, PLoS One, 11, e0162578, 10.1371/journal.pone.0162578

Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925

Andersen, 1997, Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic, Antimicrob. Agents Chemother., 41, 218, 10.1128/AAC.41.1.218

Aristoff, 2010, Rifamycins—obstacles and opportunities, Tuberculosis, 90, 94, 10.1016/j.tube.2010.02.001

Baysarowich, 2008, Rifamycin antibiotic resistance by ADP-ribosylation: structure and diversity of Arr, Proc. Natl. Acad. Sci. USA, 105, 4886, 10.1073/pnas.0711939105

Beam, 2009, Crystal structure of Baeyer-Villiger monooxygenase MtmOIV, the key enzyme of the mithramycin biosynthetic pathway, Biochemistry, 48, 4476, 10.1021/bi8023509

Bliziotis, 2007, Rifampin as adjuvant treatment of Gram-positive bacterial infections: a systematic review of comparative clinical trials, Eur. J. Clin. Microbiol. Infect. Dis., 26, 849, 10.1007/s10096-007-0378-1

Brown, 2016, Antibacterial drug discovery in the resistance era, Nature, 529, 336, 10.1038/nature17042

Bunkoczi, 2011, Improvement of molecular-replacement models with Sculptor, Acta Crystallogr. Section D Biol. Crystallogr., 67, 303, 10.1107/S0907444910051218

Campbell, 2001, Structural mechanism for rifampicin inhibition of bacterial RNA polymerase, Cell, 104, 901, 10.1016/S0092-8674(01)00286-0

Casey, 1975, Determination of the solution conformation of rifamycin S and derivatives by nuclear magnetic resonance, J. Am. Chem. Soc., 97, 6231, 10.1021/ja00854a048

Cox, 2017, A common platform for antibiotic dereplication and adjuvant discovery, Cell Chem. Biol., 24, 98, 10.1016/j.chembiol.2016.11.011

Crozier-Reabe, 2012, Form follows function: structural and catalytic variation in the class a flavoprotein monooxygenases, Int. J. Mol. Sci., 13, 15601, 10.3390/ijms131215601

Dabbs, 1987, Rifampicin inactivation by Rhodococcus and Mycobacterium species, FEMS Microbiol. Lett., 44, 395, 10.1111/j.1574-6968.1987.tb02320.x

DuPont, 2007, Therapy for and prevention of traveler's diarrhea, Clin. Infect. Dis., 45, S78, 10.1086/518155

Emsley, 2010, Features and development of Coot, Acta Crystallogr. Section D Biol. Crystallogr., 66, 486, 10.1107/S0907444910007493

Entsch, 1976, Flavin-oxygen derivatives involved in hydroxylation by p-hydroxybenzoate hydroxylase, J. Biol. Chem., 251, 2550, 10.1016/S0021-9258(17)33523-8

Forsberg, 2015, The tetracycline destructases: a novel family of tetracycline-inactivating enzymes, Chem. Biol., 22, 888, 10.1016/j.chembiol.2015.05.017

Gallo, 1976, Rifampicin, 467, 10.1016/S0099-5428(08)60328-7

Hoshino, 2010, Monooxygenation of rifampicin catalyzed by the rox gene product of Nocardia farcinica: structure elucidation, gene identification and role in drug resistance, J. Antibiot., 63, 23, 10.1038/ja.2009.116

Koskiniemi, 2007, Crystal structures of two aromatic hydroxylases involved in the early tailoring steps of angucycline biosynthesis, J. Mol. Biol., 372, 633, 10.1016/j.jmb.2007.06.087

Krissinel, 2004, Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions, Acta Crystallogr. Section D Biol. Crystallogr., 60, 2256, 10.1107/S0907444904026460

Krissinel, 2007, Inference of macromolecular assemblies from crystalline state, J. Mol. Biol., 372, 774, 10.1016/j.jmb.2007.05.022

Laskowski, 2011, LigPlot+: multiple ligand-protein interaction diagrams for drug discovery, J. Chem. Inf. Model., 51, 2778, 10.1021/ci200227u

Liu, 2016, The structure of the antibiotic deactivating, N-hydroxylating rifampicin monooxygenase, J. Biol. Chem., 291, 21553, 10.1074/jbc.M116.745315

Maggi, 1966, Rifampicin: a new orally active rifamycin, Chemotherapy, 11, 285, 10.1159/000220462

Minor, 2006, HKL-3000: the integration of data reduction and structure solution—from diffraction images to an initial model in minutes, Acta Crystallogr. Section D Biol. Crystallogr., 62, 859, 10.1107/S0907444906019949

Moore, 2005, Tigecycline is modified by the flavin-dependent monooxygenase TetX, Biochemistry, 44, 11829, 10.1021/bi0506066

O'Neil, 2001

Park, 2017, Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes, Nat. Chem. Biol., 13, 730, 10.1038/nchembio.2376

Qi, 2016, Structural basis of rifampin inactivation by rifampin phosphotransferase, Proc. Natl. Acad. Sci. USA, 113, 3803, 10.1073/pnas.1523614113

Ramaswamy, 1998, Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update, Tubercle Lung Dis., 79, 3, 10.1054/tuld.1998.0002

Risley, 1980, Oxygen-18 isotope effect in carbon-13 nuclear magnetic resonance spectroscopy. 2. The effect of structure, J. Am. Chem. Soc., 102, 4609, 10.1021/ja00534a007

Ryan, 2007, Crystallographic trapping in the rebeccamycin biosynthetic enzyme RebC, Proc. Natl. Acad. Sci. USA, 104, 15311, 10.1073/pnas.0707190104

Santos, 2001, NMR studies of some rifamycins, J. Mol. Struct., 563, 61, 10.1016/S0022-2860(00)00871-1

Schmittgen, 2008, Analyzing real-time PCR data by the comparative C(T) method, Nat. Protoc., 3, 1101, 10.1038/nprot.2008.73

Spanogiannopoulos, 2012, Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetes, Antimicrob. Agents Chemother., 56, 5061, 10.1128/AAC.01166-12

Spanogiannopoulos, 2014, A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria, Proc. Natl. Acad. Sci. USA, 111, 7102, 10.1073/pnas.1402358111

Stogios, 2016, Rifampin phosphotransferase is an unusual antibiotic resistance kinase, Nat. Commun., 7, 11343, 10.1038/ncomms11343

Studier, 2005, Protein production by auto-induction in high density shaking cultures, Protein Expr. Purif., 41, 207, 10.1016/j.pep.2005.01.016

van Berkel, 2006, Flavoprotein monooxygenases, a diverse class of oxidative biocatalysts, J. Biotechnol., 124, 670, 10.1016/j.jbiotec.2006.03.044

Vederas, 1980, Biosynthesis of averufin by Aspergillus parasiticus; detection of 18O-label by 13C-N.M.R. isotope shifts, J. Chem. Soc. Chem. Commun., 183, 10.1039/c39800000183

Vekey, 1989, Liquid chromatographic-mass spectrometric studies on rifamycin antibiotics, J. Chromatogr., 474, 317, 10.1016/S0021-9673(01)93925-1

Volkers, 2011, Structural basis for a new tetracycline resistance mechanism relying on the TetX monooxygenase, FEBS Lett., 585, 1061, 10.1016/j.febslet.2011.03.012

Wright, 2005, Bacterial resistance to antibiotics: enzymatic degradation and modification, Adv. Drug Deliv. Rev., 57, 1451, 10.1016/j.addr.2005.04.002

Wright, 2007, The antibiotic resistome: the nexus of chemical and genetic diversity, Nat. Rev. Microbiol., 5, 175, 10.1038/nrmicro1614